| Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (NCT03747497) | MicuRx | 2018-11-15 |
| Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection (NCT02925416) | The Medicines Company | 2017-01-24 |
| Fosfomycin I.v. for Treatment of Severely Infected Patients (NCT02979951) | Infectopharm Arzneimittel GmbH | 2016-12-01 |
| A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004) (NCT02477514) | Merck Sharp & Dohme LLC | 2015-06-01 |
| Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) (NCT02276482) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-03-25 |
| Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections (NCT01619410) | University of Chicago | 2012-01-01 |
| Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord (NCT01369251) | ASST Fatebenefratelli Sacco | 2011-05-01 |
| Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections (NCT00948142) | Arrevus Inc. | 2009-08-01 |
| Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections (NCT00761215) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-09-17 |
| Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age (NCT00488345) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-12-01 |
| Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections (NCT00368537) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2) (NCT00303550) | Arpida AG | 2006-03-01 |
| Avelox in Complicated Skin and Skin Structure Infections (NCT00997997) | Bayer | 2005-10-01 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (NCT00210899) | Basilea Pharmaceutica | 2005-09-01 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (NCT00228982) | Basilea Pharmaceutica | 2004-10-01 |
| A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections (NCT00249197) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-01-01 |